Market Research Blog

According to the FMI report, the global clinical trials market was valued over US$ 90 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2019 to 2029. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials market from 2019 to 2029

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018. The healthcare sector is closing in on a new era of clinical trials, which are more engaged with patients, streamlined and connected. With development costs reaching record highs and patents approaching cliffs, companies are strengthening their R&D efforts to keep pace with change. Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases.

The ubiquity digital technologies is evidently growing, as these (including but not limited to ingestible devices, sensors, and wearable health monitors) hold the potential to disrupt the aspects of clinical trials. Digital technologies are revolutionizing the antiquated process of new drug development, even as optimizing the way health data is collected, measured, and assessed.

Download the Sample copy of Report with Table of Contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-384

According to the study, the clinical trials landscape is witnessing a paradigm shift toward patient centricity, in a bid to incorporate perspective of patients during the clinical trial design. Clinical trial sponsors have aligned their methods with the voice of patients, by launching communication channels during the study’s execution. Key enterprises are adopting unconventional approaches by implementing site-centric method, using operational support systems and technology for bringing studies to the trial-naïve physicians.

Industry Sponsors Account for Majority Clinical Trial Spending

The most remarkable advances in medicine are realized from sponsorships of companies for clinical trials, in the anticipation of turning a profit. A notable percentage of clinical trials being conducted to support approval of vaccines, devices, or drugs, and track their safety, have been industry-sponsored in recent years.

The study estimates industry-sponsored clinical trials to account for ~60% of overall spending in 2019, and in the foreseeable future. Recent studies state that industry-sponsored trials yield positive results compared to academic-run trials, which also account for a significant share of clinical trial spending.

Preview analysis of Clinical Trials Market is segmented by (Area – Oncology, Infectious Disease, Metabolic Disorders, Cardiovascular, Neuroscience, Respiratory & Others; Phase – Phase 0,Phase I,Phase II, Phase III & Phase IV; Sponsor – Industry-sponsored, Government / Public, Non-governmental Organizations & Others (Academic Medical Centers, Individuals, etc.);) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2029: https://www.futuremarketinsights.com/reports/clinical-trials-market

According to FMI, sponsors, such as academic institutes, research institutes and medical centers, are estimated to account for ~30% clinical trial spending in 2019. As the imperativeness of evidence-based therapies continue to be progressively emphasized, most of the randomized clinical trials are driven by the ability of developing profitable new therapies. Guidelines recommended by regulatory bodies for clinical trial enrichment, and risk-based monitoring are likely to lay the groundwork for more targeted approach toward cost-intensive clinical trials.

The study opines that North America and Europe will continue to lead the clinical trials landscape, collectively accounting for ~80% of global spending. These regions present a standardized and favorable environment for the clinical trials landscape, in light of their economic vigor that enables them to benefit from most of the technology disruptions prior to other nations. Pharmaceutical and medical device giants in these two regions are adopting AI for disrupting every stage of the clinical trial, which range from linking studies to eligible patients, to data collection and adherence.

Buy this report @ https://www.futuremarketinsights.com/checkout/384

According to the study, opportunities abound for conducting clinical trials in developing economies, such as in East Asia and South Asia, owing to the access to huge patient pool. Sponsors are likely to realize greater success in these regions as low government healthcare budgets represent cost-effective methods of providing patients with access to innovative therapies. Additionally, conducting clinical trials in these regions comes with other broader advantages, including pragmatic & efficient regulatory pathway, and tax incentives for conducting the trials.

Key Segment

By Area

• Oncology
• Infectious Disease
• Metabolic Disorders
• Cardiovascular
• Neuroscience
• Respiratory
• Others

By Phase

• Phase 0
• Phase I
• Phase II
• Phase III
• Phase IV

By Sponsor

• Industry-sponsored
• Government / Public
• Non-governmental Organizations
• Others (Academic Medical Centers, Individuals, etc.)

By Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

Competition Landscape in Clinical Trials Market

Laboratory Corporation of America Holdings, IQVIA, Inc., Syneos Health, Parexel International Corporation, PRA Health Sciences, Inc., PPD, Inc., Icon plc, Charles River Laboratories, Inc., WuXi AppTec, and Medpace Holdings, Inc.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/customization-available/rep-gb-384

The global small bore connectors market has witnessed increased interest in the last couple of decades, resulting in a steady growth at a moderate pace, attributed to increased focus on minimizing the risk of misconnections. The study by Future Market Insights on the prospective growth of the market estimates that the small bore connectors market is likely to grow at an average of approximately 4% globally, during the course of the forecast period from 2019 to 2029.

With healthcare as an industry shifting towards value-based care, that places patient safety at the centre, the demand for better quality of medical devices is on the rise, showing no signs of abating.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3730

Improving Patient Safety and Standardised Products

Improving patient safety is one of the biggest tenets of value-based healthcare, this applies to medical device connectors to reduce the risk of tubing misconnections. Since the invention of small bore connectors, there has been continuous research and development into improving quality to mitigate the risks to the patient. Some of the aspects that manufactures in the landscape are focusing on include stress cracking, fluid leakage, resistance to overriding, all of which are crucial factors impacting the small bore connectors market.

Players in the market are looking to increasingly expand their product range to include features such as product readiness for compatibility with diverse applications and improved quality of products. This has also led to prominent players working towards standardizing their products to eliminate the potential risk of using non-standard small bore connectors, contributing positively to the growth and expansion of the small bore connectors market.

Request Special Price for this Report to our Sales Executive@ https://www.futuremarketinsights.com/ask-question/rep-gb-3730

Regional Analysis within the Global Scenario

With new standards governing the quality and reducing the errors in small bore connectors, the use of small bore connectors has remained significantly large in intravascular administration of medicine, with over a fourth of the total sales. But, their use in enteral administration of medicine is also getting quickly popular in recent years.

According to this study on the small bore connectors market by Future Market Insights, the regional markets in North America and Europe currently hold the largest share of the global market, as of 2019. This can be attributed to comparative pricing by manufacturers in these regions, and is expected to stay the same over the forecast period, accounting for nearly 50% of the share as a whole. The regional markets in developing countries are projected to remain fairly benign during the same tenure.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-3730

Technology and Improvement in Quality With application-specific designs and products being introduced by the manufacturers of small bore connectors, and innovation for safer and better products becoming central to the business strategies of these players, the growth of the market is likely to be steady in the near future. They are looking to leverage technology to focus on consistency and compatibility to alleviate the risk of misconnection. All of these drivers are being considered crucial aspects that are likely to shape the small bore connectors market landscape.

Deflectable catheters are used for minimally invasive procedures such as coronary interventions and electrophysiology applications. Due to the upgradation of technology, the core tip can deflect at a certain angle. According to the latest research by FMI, the global deflectable catheters market is expected to account for more than US$ 2,400.0 Mn in terms of value by the end of 2029. The deflectable catheters market report also projects a significant growth potential in the market with a CAGR of ~ 4% during the forecast period.

Companies Eyeing Untapped Opportunities in Cost-sensitive Regional Markets

The current adoption pattern among healthcare professionals favour the use of reposable medical devices, a trend that is most certainly observed in developing countries, to complement the cost factor and availability. In contrast, most of the deflectable catheters used are one-time use products. Factors like blood, debris prevent using reposable deflectable catheters in operations as critical as electrophysiology.

Download the Sample copy of Report with Table of Contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5852

The usage of reposable deflectable catheters is significantly higher in developing economies with inadequate resources, where the cost of treatment can be significantly high, which is unfavourable for patients from poor backgrounds. The present cost structure with the use of reposable deflectable catheters makes it feasible for a sizeable population to opt for low-cost treatment options, which help boost the adoption rate, and thereby expand the consumer pool.

At present, there are only a few companies offering reposable deflectable catheters, and none of the major players are into developing reposable devices. As per the report, a comparatively smaller company, CathRx, has a similar reposable product, Khelix, which is considered to be the first ‘reposable’ diagnostic and therapeutic catheter for the treatment of cardiac arrhythmias.

Acquisitions & Collaborations Playing Decisive Role in Shaping Deflectable Catheters Market Structure

The affective adjustments and development observed in the parent market influences the deflectable catheters market. The recent trend of involving digital methods for diagnosing cardiac problems is also changing the treatment pattern. All these trends are more governed by the top market leaders in the cardiology market. With abundant resources and investment plans, they manipulate the industry in a way in which no other smaller or regional manufacturer is capable of keeping pace with them.

Preview analysis of Deflectable Catheters Market is segmented by (Product Type – uni-directional deflectable catheters, bi-directional deflectable catheters and multi-directional deflectable; Application – coronary interventions, electrophysiology, diagnostics imaging and peripheral interventions; End User – hospitals, office based clinics, ambulatory surgical centers and independent catheterization labs;) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2029: https://www.futuremarketinsights.com/reports/deflectable-catheters-market

The trend of acquisition and forming a strategic partnership is positive delivering financial results. For example, Abbott’s acquisition of St. Jude Medical resulted in the consolidation of the 2nd and 4th largest cardiology market players. Moreover, the acquisition of specific treatment technologies has also been observed in the deflectable catheter market, and there has been an increase in the number of players expanding their product portfolio for the treatment of atrial fibrillation/atrial flutter.

Deflectable Catheters Market: Segmental Analysis

On the basis of product type, the deflectable catheters market has been segmented into uni-directional deflectable catheters, bi-directional deflectable catheters, and multi-directional deflectable catheters. Bi-directional deflectable catheters lead the market due to their high adoption rate and availability.

Based on application, the deflectable catheters market has been segmented into coronary interventions, electrophysiology, diagnostics imaging, and peripheral interventions. In terms of revenue, the electrophysiology segment is expected to have a major share in the deflectable catheters market due to an increase in the number of procedures being carried out by deflectable catheters.

Buy this report @ https://www.futuremarketinsights.com/checkout/5852

On the basis of end user, the deflectable catheters market has been categorised into hospitals, office-based clinics, ambulatory surgical centres, and independent catheterisation labs. Independent catheterisation labs are expected to witness significant growth, which is driven by an increase in the number of the same.

Some of the key players in the deflectable catheters market include Medtronic Plc, Merit Medical Systems, JOHNSON & JOHNSON, Teleflex Incorporated, Boston Scientific Corporation, Biomerics LLC, OSYPKA AG, Abbott, Japan Lifeline Co., CathRx Ltd., and Biotronik SE & Co. KG.

The rising prevalence of urinary incontinence in pregnant women, stress urinary incontinence due to diabetes, gynaecology disorders, and urinary incontinence in postmenopausal women are some of the major factors propelling the growth of the female stress urinary incontinence treatment devices market. Several other risk factors that increase the risk of developing stress urinary incontinence in women include high body weight, type of childbirth, age, pelvic surgery, etc.

A few medical conditions such as enlarged prostate, muscle damage, excess urine formation, multiple sclerosis, Parkinson’s disease, spinal cord injury, and loss of storage capacity in the rectum are also expected to boost the incidence of stress urinary incontinence among women, which is fuelling the demand for female stress urinary incontinence treatment devices.

The practice of using female stress urinary incontinence treatment devices has changed dramatically over the past decade. The number of procedures undertaken appears to be increasing, and the shift in relative numbers of different procedures has been remarkable. For instance, in England, the annual number of operations undertaken using female stress urinary incontinence treatment devices between 1997-1998 and 2005-2006 increased by 28%, despite a reduction of over 90% in the number of colposuspension and needle suspension procedures.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-2533

Healthy Revenue Growth Projected through 2029

According to latest research by FMI, the global female stress urinary incontinence treatment devices market is estimated to have accounted for ~ US$ 560 Mn in terms of value in 2018. The report on the female stress urinary incontinence treatment devices market further projects that the female stress urinary incontinence treatment devices market is likely to grow at a CAGR of ~ 6% during the period 2019-2029.

However, due to the presence of wide range of products in the female stress urinary incontinence treatment devices market, small players are gaining interest and are selling their products at a lower price. Increase in the penetration of private-label brands at much lower prices is expected to decrease the average overall price of female stress urinary incontinence treatment devices. This is likely to restrain the growth of the global female stress urinary incontinence treatment devices market, as it is likely to hamper the demand for expensive products.

Preview Analysis Global Female Stress Urinary Incontinence Treatment Devices Market Segmentation by Product Type (Sling System, Pessaries); by End Use (Hospitals, Gynaecological Clinics, Homecare Settings): https://www.futuremarketinsights.com/reports/female-stress-urinary-incontinence-treatment-device-market

Rapid changes have taken place in developing countries over the past few years. The improper implementation of regulatory guidelines and the lack of proper healthcare infrastructure in developing regions, such as the Middle East & Africa and Latin America, are among factors that are expected to restrain the growth of the female stress urinary incontinence treatment devices market.

50% Revenue Shares Accounted by North America

The female stress urinary incontinence treatment devices market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa. North America, followed by Europe, is a prominent region in the global female stress urinary incontinence treatment devices market. North America accounted for a revenue share of about 50% in 2018 in the female stress urinary incontinence treatment devices market. Europe also accounted for a prominent revenue share, and is followed by East Asia in the female stress urinary incontinence treatment devices market.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-2533

The female stress urinary incontinence treatment devices market report tracks some of the key companies operating in female stress urinary incontinence treatment devices market, such as Boston Scientific Corporation, BD, Coloplast Corporation, Caldera Medical, and Ethicon US LLC (Johnson & Johnson Services, Inc.). Majority of the key regional players in the female stress urinary incontinence treatment devices market highly focused on expanding their product connectivity and reach with the help of domestic distributors of female stress urinary incontinence treatment devices. Moreover, the manufacturers of female stress urinary incontinence treatment devices are focused to strengthening their businesses in high-growth markets, such as India, Japan, and China, by expanding their distribution and sales channels.

Buy Female Stress Urinary Incontinence Treatment Devices Market Research Report @ https://www.futuremarketinsights.com/checkout/2533

More from FMI’s Healthcare, Pharmaceuticals and Medical devices Market Intelligence:

• Soft Tissue Repair Market– Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017- 2022
• Rapid RNA testing kits Market– Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2028
• Automated Microplate Handling Systems Market– Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2028

The growth of the HDL cholesterol kits market can be attributed to the increasing prevalence of atherosclerosis due to high cholesterol level, which favours the demand for cholesterol testing. According to the latest research by FMI, the global HDL cholesterol kits market is expected to be valued at US$ 790 Mn by the end of 2029. The HDL cholesterol kits market is expected to expand at a CAGR of 5.0% during the forecast period 2019-2029.

The increasing incidence of obesity and hyperlipidaemia among people is boosting the need for cholesterol testing, which is driving the growth of the HDL cholesterol kits market. The prevalence of obesity has increased from 33.7% in 2007-2008 to 39.7% in 2015-2016 among adults in the U.S. The increasing prevalence of obesity also increases the risk of cardiovascular disorders, high blood pressure, and hyperlipidaemia. Moreover, the prevalence of hyperlipidaemia is high among the obese population. Nearly 60-70% of patients suffering from obesity have hyperlipidaemia. Other factors, such as growing awareness programs for cholesterol testing and growing cholesterol testing among diabetic patients, are also propelling the growth of the HDL cholesterol kits market.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-9842

Rise of ‘Regular Health Check’ Trend Uplifts Prospects in East Asia

Low awareness in middle- and low-income countries about cholesterol testing and other healthcare testing are also among the major factors that are expected to hamper the growth of the HDL cholesterol kits market. There is low awareness about diseases such as dyslipidaemia and hypercholesterolemia in middle-income countries and rural areas. Moreover, the chances of errors and inaccuracy in HDL cholesterol testing methods, such HDL cholesterol precipitating method, are among factors expected to restrain the growth of the HDL cholesterol kits market.

The North America HDL cholesterol kits market gain a maximum value share in 2018. However, the East Asia HDL cholesterol kits market expected to witness prominent growth owing to the higher demand for cholesterol testing in countries such as China and Japan. Developing countries, such as China and India, represent a significant growth rate in the HDL cholesterol kits market due to the growing adoption of regular healthcare testing. The Middle East & Africa HDL cholesterol kits market is expected to witness a sluggish growth rate as compared to other regions.

Preview Analysis Global HDL Cholesterol Kits Market Segmentation By Product Type (HDL Cholesterol Precipitating Reagent Kit, HDL Cholesterol Direct Reagent Kit, HDL and LDL/VLDL Assay Kit); By End User (Hospitals, Clinics, Diagnostic Laboratories): https://www.futuremarketinsights.com/reports/hdl-cholesterol-kits-market

The global HDL cholesterol kits market has been studied based on the product type and end user. Based on the product type, the HDL cholesterol kits market has been segmented into HDL cholesterol precipitating reagent kit, HDL cholesterol direct reagent kit, and HDL and LDL/VLDL assay kit. The HDL and LDL/VLDL assay kit product type segment is expected to hold a prominent share in the global HDL cholesterol kits market. Based on end user, the HDL cholesterol kits market has been segmented into hospitals, clinics, and diagnostic laboratories. In terms of revenue, the hospitals segment of the HDL cholesterol kits market was a significant market for HDL cholesterol kits in 2018.

Partnerships and Acquisitions Governing the Competition Landscape

Some of the key players operating in the HDL cholesterol kits market are Diazyme Laboratories, Inc., Randox Laboratories Limited, Fujifilm Holding Corporation, Thermo Fisher Scientific, Abcam plc., Merck KGaA, Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), PerkinElmer, Inc., and Hoffmann-La Roche Ltd.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-9842

Players in the HDL cholesterol kits market are focusing on partnerships and acquisitions with regional and global players to increase their sales worldwide. For instance, through the acquisition of Wako Pure Chemical, Fujifilm Holding Corporation expand its presence in the life science and chemical sectors. The manufacturers of HDL cholesterol kits are focusing on the expansion of their presence in key markets such as the Asia Pacific, the Middle East, and Europe through distribution agreements and the opening of new manufacturing facilities. The manufacturers of HDL cholesterol kits are also focusing on the development of point-of-care testing as it is more helpful and convenient for making quicker decisions. Moreover, HDL cholesterol kits industry stakeholders are focusing on the addition of direct reagent kits in their product portfolios.

A recent market study published by FMI “HIV/HBV/HCV Test Kits Market: Global Industry Analysis and Forecast” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the HIV/HBV/HCV test kits market, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report commences with the executive summary of the HIV/HBV/HCV test kits market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the HIV/HBV/HCV test kits market.

Chapter 02 – Market Overview

Readers can find the detailed taxonomy and the definition of the HIV/HBV/HCV test kits market in this chapter, which will help them understand the basic information about the HIV/HBV/HCV test kits market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the HIV/HBV/HCV test kits market report.

Chapter 03 – Key Success Factors

This section includes the key inclusions of the report. It includes the HIV & hepatitis B & C testing and the diagnostic strategy, patient journey, new HIV infected population, global average pricing analysis benchmark, consumer sentiment analysis, and value chain analysis, which are likely to contribute to market growth.

To Know More About This Market, Request A Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9814

Chapter 04 – Global HIV/HBV/HCV Test Kits Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019–2029

This section explains the global market value analysis and forecast for the HIV/HBV/HCV test kits market between the forecast period of 2014-2029. This chapter includes the detailed analysis of the historical HIV/HBV/HCV test kits market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019-2020), and an incremental opportunity for the forecast period (2019-2029).

Chapter 05- Global HIV/HBV/HCV Test Kits Market – Pricing Analysis

This section highlights the average price of HIV, HBV, and HCV test kits in different regions across the globe.

Chapter 06 – Market Background

This chapter explains the key macro-economic factors that are expected to influence the growth of the HIV/HBV/HCV test kits market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the HIV/HBV/HCV test kits market. This chapter also highlights the key market dynamics of the HIV/HBV/HCV test kits market, which include the drivers, restraints, and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the HIV/HBV/HCV test kits market.

Chapter 07 – Global HIV/HBV/HCV Test Kits Market Analysis 2014 – 2018 & 2019–2029, By Kit Types

Based on kit types, the HIV/HBV/HCV test kits market is segmented into assay-based test kits, rapid test kits, and combination rapid test kits. Readers can find information about the key trends and developments in the HIV/HBV/HCV test kits market and market attractiveness analysis based on the kit types.

Chapter 08 – Global HIV/HBV/HCV Test Kits Market Analysis 2014 – 2018 & Forecast 2019–2029, by Sample Type

Based on sample type, the HIV/HBV/HCV test kits market is segmented into blood, urine, and saliva. In this chapter, readers can find information about the key trends and developments in the HIV/HBV/HCV test kits market and market attractiveness analysis based on sample type used for the detection of HIV, HBV, and HCV infections.

Chapter 09 – Global HIV/HBV/HCV Test Kits Market Analysis 2014 – 2018 & Forecast, 2019–2029, By End User

This chapter provides details about the HIV/HBV/HCV test kits market on the basis of end user, and has been classified into hospitals, clinics, diagnostic laboratories, government organizations & NGOs, and others. In this chapter, readers can understand the market attractive analysis based on end user.

Download TOC @ https://www.futuremarketinsights.com/reports/hiv-hbv-hcv-test-kits-market/table-of-content

Chapter 10 – Global HIV/HBV/HCV Test Kits Market Analysis 2014 – 2018 & Forecast, 2019–2029, By Region

This chapter explains how the HIV/HBV/HCV test kits market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.